March 2018 - Volume 33 - Issue 2 - Contributor Index

Alphabetical Search
E
I
J
M
Q
U
X
Y

Pexacerfont as a CRF1 antagonist for the treatment of withdrawal symptoms in men with heroin/methamphetamine dependence: a randomized, double-blind, placebo-controlled clinical...

Morabbi, Mohammad-Javad; Razaghi, Emran; Moazen-Zadeh, Ehsan; More

International Clinical Psychopharmacology. 33(2):111-119, March 2018.

Pexacerfont as a CRF1 antagonist for the treatment of withdrawal symptoms in men with heroin/methamphetamine dependence: a randomized, double-blind, placebo-controlled clinical...

Morabbi, Mohammad-Javad; Razaghi, Emran; Moazen-Zadeh, Ehsan; More

International Clinical Psychopharmacology. 33(2):111-119, March 2018.